Impact Report IMPACT REPORT 2022 – 2023 2022 – 2023 __________ My Story My Story Karen Noel After 25 years as a teacher, many of them working with special […]
PARATHYROID HORMONE (PTH) A new class of osteoporosis treatments called bone formation agents Parathyroid hormone analogues belong to a class of osteoporosis medications which can promote bone growth. In Canada, […]
2023 Clinical Practice Guideline Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update. This guideline is an update of the 2010 Osteoporosis Canada clinical practice […]
It is well known that calcium is a necessary nutrient because it plays an essential role in human health, not only for bone development but also for the heart, muscle […]
Last week, Osteoporosis Canada heard a news story that suggested that there is an increased risk of developing osteonecrosis of bone if you are taking a bisphosphonate medication for osteoporosis. […]
Tools Algorithm 1 Integrated approach to the management of bone health and fracture prevention in postmenopausal females and males 50 years and older. DOWNLOAD Algorithm 2 Approach to pharmacotherapy to […]
Osteoporosis is a common but often overlooked disease in men – a broken bone may be the first sign you have it. Often, osteoporosis in men can be secondary to […]
Latest News A New Clinical Practice Guideline for management of osteoporosis and fracture prevention in Canada October 10, 2023 On October 10, 2023, a new guideline on managing osteoporosis to […]
